From Casetext: Smarter Legal Research

Miller-Rich v. Altum Pharm.

United States District Court, S.D. New York
Oct 26, 2022
1:22-cv-03473 (JLR) (S.D.N.Y. Oct. 26, 2022)

Opinion

1:22-cv-03473 (JLR)

10-26-2022

NANCY MILLER-RICH, Plaintiff, v. ALTUM PHARMACEUTICALS INC., et al., Defendants.


ORDER

JENNIFER L. ROCHON, DISTRICT JUDGE

The Court is in receipt of the parties' joint letter regarding the status of discovery in this action, dated October 25, 2022. ECF No. 32. Discovery has been stayed while the parties participate in the Court-annexed Mediation Program, and the parties indicate that they believe a further stay is warranted. Id. Accordingly, IT IS HEREBY ORDERED that any party seeking a stay of discovery pending a decision on the anticipated motion to dismiss shall file a letter, not to exceed two pages, delineating the basis for the stay no later than November 2, 2022. IT IS FURTHER ORDERED that any party opposing such a stay shall file a letter in response, not to exceed two pages, no later than November 7, 2022.

As to the anticipated motion to dismiss, the parties request permission to file an opening memorandum of law and memorandum of law in opposition limited to thirty-five (35) pages, and a reply memorandum of law not to exceed twenty (20) pages. The parties' assertion that there will be a number of complex issues is insufficient to justify an extension of the already ample page limits. Accordingly, the request is DENIED.

SO ORDERED.


Summaries of

Miller-Rich v. Altum Pharm.

United States District Court, S.D. New York
Oct 26, 2022
1:22-cv-03473 (JLR) (S.D.N.Y. Oct. 26, 2022)
Case details for

Miller-Rich v. Altum Pharm.

Case Details

Full title:NANCY MILLER-RICH, Plaintiff, v. ALTUM PHARMACEUTICALS INC., et al.…

Court:United States District Court, S.D. New York

Date published: Oct 26, 2022

Citations

1:22-cv-03473 (JLR) (S.D.N.Y. Oct. 26, 2022)